| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |